【와티비커뮤니티-WATVcommunity】 보증업체놀이터추천홍보 : 프로그램제작판매제작의뢰 : 스포츠분석 : 무료스포츠중계tv : 섹시bj움짤 : 스포츠뉴스 : 안구정화 놀이터홍보 놀이터후기공유 피해사례공유

로그인

채팅

글쓰기

[IT뉴스]Hanmi Shifts to "Professional Management System"

온카뱅크관리자

2025-03-06 10:27:28

<strong class="summary_view" data-translation="true">Board of Directors Approves Nominees for Shareholders‘ Meeting on March 26<br>Kim Jae-kyo, Former Meritz Securities Vice President, Set to Become CEO</strong> 
        <div class="article_view" data-translation-body="true" data-tiara-layer="article_body" data-tiara-action-name="본문이미지확대_클릭"> 
         <section dmcf-sid="3zQnxAkPO7">
          <p contents-hash="c45bd1eb2e94eb0ec6f4e0f3c76ba2f8c9112916aad0d2d2799d80c36ffe0f79" dmcf-pid="0qxLMcEQDu" dmcf-ptype="general"> [Seok Ji-hoen, Edaily Reporter] Hanmi Science, the holding company of Hanmi Pharmaceutical Group, and its key business unit, Hanmi Pharmaceutical, each held board meetings on March 5 to finalize nominees for their boards of directors. These candidates will be presented for approval at the regular shareholders’ meeting on March 26.</p>
          <figure class="figure_frm origin_fig" contents-hash="dea9816b01275f15a96d6ef62e7b3bb311129a7e1e8fc70f3af19928bff2eca7" dmcf-pid="pBMoRkDxDU" dmcf-ptype="figure">
           <p class="link_figure"><img alt="Exterior View of Hanmi Pharmaceutical Headquarters." class="thumb_g_article" data-org-src="https://t1.daumcdn.net/news/202503/06/Edaily/20250306101725618sofh.jpg" data-org-width="487" dmcf-mid="FuFq3f8trz" dmcf-mtype="image" height="auto" src="https://img2.daumcdn.net/thumb/R658x0.q70/?fname=https://t1.daumcdn.net/news/202503/06/Edaily/20250306101725618sofh.jpg" width="658"></p>
           <figcaption class="txt_caption default_figure">
            Exterior View of Hanmi Pharmaceutical Headquarters.
           </figcaption>
          </figure>
          <div contents-hash="ea401a851f2b4a009148b55b2ed3a68a75e23bbb68063485e1ce76cd84d8a770" dmcf-pid="U9dNJwmewp" dmcf-ptype="general">
           The group is implementing an advanced governance structure in which professional managers oversee operations, while major shareholders provide support and oversight. This initiative marks a new chapter for Hanmi Pharmaceutical Group as it strengthens its corporate governance.
          </div>
          <p contents-hash="ed93e90605b78b3e7691cc71b4760a296e1e66ec1b43915fdb52b5759e535a98" dmcf-pid="u2Jjirsdm0" dmcf-ptype="general">Hanmi Science’s board has proposed four internal director nominees: Im Joo-hyun, vice chairman of Hanmi Science and Hanmi Pharmaceutical, Kim Jae-kyo, former vice president of Meritz Securities, Shim Byung-hwa, former executive director at Samsung Biologics and Kim Sung-hoon, former executive director at Hanmi Science. Additionally, three external director nominees have been selected, Choi Hyun-man, former CEO of Mirae Asset Securities, Kim Young-hoon, former judge at the Seoul High Court and Shin Yong-sam, professor at the Catholic University of Korea’s Seoul St. Mary’s Hospital.</p>
          <p contents-hash="6595e8ce18c8a3567879bc3dc4345046b8428194ed6d51ae241e8b1c232dee6e" dmcf-pid="7ViAnmOJs3" dmcf-ptype="general">Kim Jae-kyo, one of the nominees, has been appointed as the next CEO and recently joined Hanmi Science as vice chairman. Meanwhile, Shim Byung-hwa has been named the new chief financial officer (CFO) and has taken on the role of vice president.</p>
          <p contents-hash="c6eb8cf8ed214b7e249f5459b07fa2f4eaa965bf56d0d1af16a9f79cb7af8d50" dmcf-pid="zfncLsIiwF" dmcf-ptype="general">Hanmi Pharmaceutical’s board, which also met on March 5, has put forward three nominees for its shareholders‘ meeting: Choi In-young, head of Hanmi Pharmaceutical’s R&amp;D Center, as an internal director, Kim Jae-kyo, former vice president of Meritz Securities, as a non-executive director and Lee Young-gu, managing attorney at law firm Daeryuk Aju, as an external director.</p>
          <p contents-hash="fb2f29a12c9da65a0bc96a1cbe7bdc518998c9b8c24375de6491af20195c6f69" dmcf-pid="q4LkoOCnmt" dmcf-ptype="general">A Hanmi Pharmaceutical Group spokesperson stated, “After overcoming various challenges over the past year, we are reinforcing our advanced governance structure and embarking on a new beginning. Through performance-driven innovation, we aim to grow alongside our customers and shareholders as a forward-looking enterprise.”</p>
          <p contents-hash="11bf0ec37200317d5c8612b707440d5315fbeac1d3bc270033486152ee735368" dmcf-pid="B8oEgIhLm1" dmcf-ptype="general">석지헌 (cake@edaily.co.kr) </p>
         </section> 
        </div> 
        <p class="" data-translation="true">Copyright © 이데일리. 무단전재 및 재배포 금지.</p>

노상현, 꾸안꾸 남친미의 정석 “물리학 한계 뛰어넘었다” 초정밀 측정 가능…초고해상도 ‘양자분광기’ 개봉 박두

댓글 총 0개

업체홍보/구인 더보기

놀이터홍보 더보기

지식/노하우 더보기

판매의뢰 더보기

포토 더보기